PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
about
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
description
im Juli 2018 veröffentlicher wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2018
@uk
name
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@en
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@nl
type
label
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@en
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@nl
prefLabel
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@en
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@nl
P2093
P2860
P1476
PARP inhibitor veliparib and H ...... mplex in prostate cancer cells
@en
P2093
Bowen Yuan
Linglong Yin
Lunquan Sun
Qianling Zhu
Xiaohui Yu
Xuegong Fan
Yingxue Gao
P2860
P2888
P356
10.1186/S13046-018-0810-7
P407
P577
2018-07-16T00:00:00Z
P6179
1105626958